Phase Ib Study of Drozitumab Combined With First-Line mFOLFOX6 Plus Bevacizumab in Patients with Metastatic Colorectal Cancer

By Rocha Lima Caio M.   Bayraktar Soley   Flores Aurea M.   MacIntyre Jessica   Montero Alberto   Baranda Joaquina C.   Wallmark John   Portera Chia   Raja Rajiv   Stern Howard   Royer-Joo Stephanie   Amler Lukas C.  

Cancer Investigation, Vol. 30, Iss. 10, 2012-12 ,pp. : 727-731

Informa Healthcare

Access to resources Recommend Favorite

A Case of Resection of Synchronous Multiple Liver Metastases from Colorectal Cancer after FOLFOX Chemotherapy

By Otsuka Shinya   Inagaki Masaru   Nishie Manabu   Hamano Ryousuke   Tokunaga Naoyuki   Takahashi Kenji   Tsunemitsu Yousuke   Miyoshi Kazuya   Takahashi Masahiko   Oosaki Toshihide   Iwagaki Hiromi  

Japanese Journal of Cancer and Chemotherapy, Vol. 36, Iss. 3, 2009-03 ,pp. : 501-504

Sunmedia

Access to resources Recommend Favorite

Polymorphisms of GSTP1, ERCC2 and TS3'UTR are associated with the clinical outcome of mFOLFOX6 in colorectal cancer patients

By                  

Oncology Letters, Vol. 6, Iss. 3, 2013-01 ,pp. : 648-654

Spandidos Publications

Access to resources Recommend Favorite

Multicenter phase II study of modified FOLFOX6 as neoadjuvant chemotherapy for patients with unresectable liver-only metastases from colorectal cancer in Japan: ROOF study

By Takahashi Takao  

International Journal of Clinical Oncology, Vol. 18, Iss. 2, 2013-04 ,pp. : 335-342

Springer Publishing Company

Access to resources Recommend Favorite

Histological liver injury and surgical outcome after FOLFOX followed by a hepatectomy for colorectal liver metastases in Japanese patients

By Komori Hiroyuki   Beppu Toru   Baba Yoshifumi   Horino Kei   Imsung Choi   Masuda Toshiro   Hayashi Hiromitsu   Okabe Hirohisa   Ootao Ryuu   Watanabe Masayuki   Takamori Hiroshi   Iyama Kenichi   Baba Hideo  

International Journal of Clinical Oncology, Vol. 15, Iss. 3, 2010-06 ,pp. : 263-270

Springer Publishing Company

Access to resources Recommend Favorite